Joanna Raszeja-Wyszomirska
Overview
Explore the profile of Joanna Raszeja-Wyszomirska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
569
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arechederra M, Bik E, Rojo C, Elurbide J, Elizalde M, Kruk B, et al.
Liver Int
. 2025 Mar;
45(4):e70049.
PMID: 40029142
Background: Primary sclerosing cholangitis (PSC) is a chronic liver disease characterised by inflammation and fibrosis of the bile ducts, conferring an increased risk of cholangiocarcinoma (CCA). However, detecting CCA early...
2.
Snijders R, Janik M, Mund M, Uhlenbusch N, Raszeja-Wyszomirska J, Gerussi A, et al.
Hepatology
. 2025 Feb;
PMID: 39970194
Background: Impaired health-related quality of life (HRQoL) contributes to the overall disease burden in autoimmune hepatitis (AIH). This study aimed to evaluate HRQoL in people with AIH and to identify...
3.
Kruk E, Krasnodebski M, Rykowski P, Figiel W, Holowko W, Raszeja-Wyszomirska J, et al.
Ann Transplant
. 2025 Jan;
30:e946485.
PMID: 39871459
BACKGROUND Acute liver failure (ALF) remains a critical concern, accounting for about 8% of all liver transplants, with acetaminophen overdose contributing to nearly half of these cases. Besides synthetic toxins,...
4.
Kosnik A, Gadomski J, Walczak-Wieteska P, Andruszkiewicz P, Raszeja-Wyszomirska J
Pol Arch Intern Med
. 2024 Oct;
134(10).
PMID: 39431285
No abstract available.
5.
Skalski M, Kornasiewicz O, Raszeja-Wyszomirska J, Konieczka A, Mlynarczyk M, Grat M
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407761
Data regarding the outcomes of liver transplantation in disabled, highly dependent, and legally incapacitated adults are scarce, likely due to the infrequency of these procedures in such populations. Multicenter studies...
6.
Golenia A, Olejnik P, Grusiecka-Stanczyk M, Zolek N, Wojtaszek E, Zebrowski P, et al.
Brain Behav
. 2024 Aug;
14(8):e3647.
PMID: 39135287
Introduction: Cognitive impairment (CI) is common in both end-stage kidney disease (ESKD) and alcohol-related liver cirrhosis. The aim of this study was to assess the prevalence and patterns of CI...
7.
Schregel I, Papp M, Sipeki N, Kovats P, Taubert R, Engel B, et al.
Liver Int
. 2024 Jul;
44(10):2687-2699.
PMID: 39037185
Background And Aims: The European Reference Network on Hepatological Diseases (ERN RARE-LIVER) launched the prospective, multicentre, quality-controlled R-LIVER registry on rare liver diseases. The aim of this study was to...
8.
Jabiry-Zieniewicz Z, Stelmach D, Jasak K, Knap-Wielgus W, Szumska A, Raszeja-Wyszomirska J, et al.
Transplant Proc
. 2024 May;
56(4):919-922.
PMID: 38729835
Aim: Assessment of the course of pregnancies and comparison of obstetric outcomes in female liver transplant recipients in the course of Wilson's disease. Methodology: Retrospective analysis of data of women,...
9.
Janik M, Kempinska-Podhorodecka A, Raszeja-Wyszomirska J, Krawczyk M, Milkiewicz M, Milkiewicz P
Pol Arch Intern Med
. 2024 Apr;
134(5).
PMID: 38655875
Introduction: Autoimmune hepatitis (AIH) is a chronic, progressive liver disease that, in most cases, may require lifelong immunosuppression. Hepatitis E virus (HEV) is a leading cause of acute, typically self‑limited...
10.
Bodys-Pelka A, Raszeja-Wyszomirska J, Jakimowicz T, Glowczynska R
Kardiol Pol
. 2023 Nov;
82(1):98-100.
PMID: 37997837
No abstract available.